Maria Angelica Cortez Selected Research

Maria Angelica Cortez Research Topics

Disease

40	Neoplasms (Cancer) 12/2021 - 06/2009
9	Lung Neoplasms (Lung Cancer) 12/2021 - 08/2012
7	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2015
3	Adenocarcinoma of Lung 02/2021 - 01/2018
3	Lymphopenia (Lymphocytopenia) 01/2020 - 12/2014
3	Carcinogenesis 01/2018 - 06/2011
2	Disease Progression 01/2020 - 10/2010
2	Adenocarcinoma 01/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 12/2019 - 01/2017
1	Carcinoma (Carcinomatosis) 02/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 11/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2018
1	Adrenocortical Carcinoma 10/2015
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Heart Neoplasms 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 11/2010
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2010

Drug/Important Bio-Agent (IBA)

12	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2009
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2015
3	Biological ProductsIBA 10/2015 - 09/2014
3	Biomarkers (Surrogate Marker)IBA 01/2012 - 06/2009
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 01/2018
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 09/2014
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019 - 01/2018
1	OligodeoxyribonucleotidesIBA 02/2021
1	Neoplasm AntibodiesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 10/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2020
1	CytokinesIBA 10/2020
1	SHP099IBA 01/2020
1	FollistatinIBA 01/2020
1	Mitogen-Activated Protein Kinase 14IBA 01/2020
1	IACS-010759IBA 01/2020
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2020
1	c-Mer Tyrosine KinaseIBA 12/2019
1	IpilimumabIBA 12/2019
1	LipidsIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	beta CateninIBA 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 11/2018
1	AntigensIBA 11/2018
1	Tumor Biomarkers (Tumor Markers)IBA 11/2018
1	TransducinIBA 11/2018
1	Co-Repressor ProteinsIBA 11/2018
1	VaccinesIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	KynurenineIBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	CyclinsIBA 11/2017
1	AntibodiesIBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2015
1	Small Interfering RNA (siRNA)IBA 10/2015
1	Galectin 1 (LGALS1)IBA 12/2014
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 12/2014
1	Proto-Oncogene Proteins c-metIBA 05/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2012
1	GoldIBA 06/2011
1	Glycoproteins (Glycoprotein)IBA 11/2010
1	mouse MIRN29 microRNAIBA 11/2010
1	3' Untranslated Regions (3' UTR)IBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010

Therapy/Procedure

21	Radiotherapy 12/2021 - 08/2012
17	Therapeutics 12/2021 - 01/2010
13	Immunotherapy 11/2021 - 09/2014
1	Radioimmunotherapy 12/2021
1	Combined Modality Therapy 12/2019
1	Drug Therapy (Chemotherapy) 10/2015
1	Lasers (Laser) 10/2010
1	Light Coagulation 10/2010